Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call

Lakewood, Colo., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced it will release financial results for its second fiscal quarter (“2Q27”) ended September 30, 2026 following market close on Monday, November 9, 2026. The Company will also hold its earnings conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.

GlobeNewsWire • Oct 28, 2026

Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity

Utz Brands shares rose after entering into an agreement to be acquired by Intersnack, a privately held European leader in savory snacks. Shares of health care management company Astrana Health declined during the quarter as selling pressure emerged following a strong first half of 2026. We initiated a position in Bank7, given its highly profitable, branch-light model and recent acquisition of Century Bank, which we believe should meaningfully enhance earnings.

Seeking Alpha • Oct 28, 2026

Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth

LAKEWOOD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa,” “we,” “us” or “our”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced a savings plan (the “Savings Plan”) expected to reduce annualized operating costs by approximately $9.3 million.

GlobeNewsWire • Oct 13, 2026

Mesa Laboratories Q1 Earnings Call Highlights

Mesa Laboratories NASDAQ: MLAB reported first-quarter fiscal 2027 revenue growth of 1%, improved operating margins and continued debt reduction, while newly appointed President and CEO Siddhartha Kadia outlined plans to address fulfillment issues in its Sterilization and Disinfection Control business and accelerate product development in Biopharmaceutical Development.

MarketBeat • Aug 11, 2026

Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript

Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript

Seeking Alpha • Aug 11, 2026

Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call

LAKEWOOD, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced it will release financial results for its first fiscal quarter (“1Q27”) ended June 30, 2026 following market close on Monday, August 10, 2026. The Company will also hold its first earnings conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.

GlobeNewsWire • Aug 3, 2026

MESA LABS DECLARES QUARTERLY DIVIDEND

Lakewood, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2026, to shareholders of record at the close of business on August 31, 2026.

GlobeNewsWire • Jul 6, 2026

Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today

Mesa Laboratories fell after reporting its Q4 fiscal 2026 results. Sales and earnings came in below Wall Street's expected earnings, but the business did report strong growth for adjusted operating income.

The Motley Fool • May 27, 2026

Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results

LAKEWOOD, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q26”) and fiscal year (“FY26”) ended March 31, 2026 (amounts in thousands).

GlobeNewsWire • May 27, 2026

Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026

LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 2026 at approximately 6:00 A.M. Eastern Time (ET) on Wednesday, May 27, 2026.

GlobeNewsWire • May 5, 2026